Black Rock Inc. Arcellx, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,066,068 shares of ACLX stock, worth $169 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,066,068
Previous 3,018,538
1.57%
Holding current value
$169 Million
Previous $168 Million
27.29%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ACLX
# of Institutions
186Shares Held
43.4MCall Options Held
73.8KPut Options Held
196K-
Perceptive Advisors LLC New York, NY3.93MShares$217 Million5.74% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.82MShares$211 Million9.96% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$207 Million18.28% of portfolio
-
Sr One Capital Management, LP2.35MShares$130 Million54.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$123 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.42B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...